Tag: leukemia

Tyrosine Kinase Inhibitor Discontinuation Can Improve CML Outcomes

NEW YORK (Reuters Health) – In patients with chronic myeloid leukemia (CML), discontinuing tyrosine kinase inhibitor (TKI) therapy is safe and associated with better patient-reported...

Are We Close to Predicting Treatment-Free Remission in CML?

A recent study in the British Journal of Haematology by Irani and colleagues suggests that an effector-suppressor score, which is calculated using absolute natural killer (NK) cell,...

Renal Function Decline With TKI Use in Chronic Myeloid Leukaemia

Renal function declines over time with tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukaemia (CML), although it is unclear if the relationship is causal,...

Cell Therapy for Anthracycline Cardiomyopathy Safe, Feasible

In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal...

FDA Approves First Maintenance Therapy for AML

The US Food and Drug Administration (FDA) has approved an oral form of azacitidine (Onureg) for use as maintenance therapy for patients with acute myeloid...

Don’t Overlook Treating Older Patients With APL, Expert Says

The estimated one third of patients with acute promyelocytic leukemia (APL) who are older than 60 years of age now enjoy a notably better prognosis...

Secondary Acute Lymphoblastic Leukemia More Lethal Than De Novo

The application of improved chemotherapy regimens and novel chemotherapy for acute lymphoblastic leukemia (ALL) has increased the complete remission rate to 85%-90%. However, secondary ALL...

Think Before Referring Lymphocytocis Patients, Urge UK Docs

Patients with asymptomatic lymphocytosis should not be referred to a haematology clinic unless they have a white cell count above a certain threshold, to avoid...

EHA Webinar Addresses Treating AML Patients With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A hematologist in Italy shared his personal experience addressing the intersection...

Genetic Test Identifies Ultra-High-Risk Myeloma Patients

A new test can identify patients with multiple myeloma (MM) who have a high-risk genetic profile as well as multiple chromosomal abnormalities. In this subgroup...